Nombre del Módulo |
1.3.5 Articulos Periodistico o Reseña de Libro |
Titulo |
Insufficient funds https://www.burleighbears.com.au/stmap_37iydmeb.html?viagra.tranexamic.cycrin alliance contract pharma Unilever said last month a further slowdown in emergingmarkets meant underlying sales growth would be 3-3.5 percent inthe third quar |
Publicacion |
Insufficient funds https://www.burleighbears.com.au/stmap_37iydmeb.html?viagra.tranexamic.cycrin alliance contract pharma Unilever said last month a further slowdown in emergingmarkets meant underlying sales growth would be 3-3.5 percent inthe third quar |
Seccion |
Insufficient funds https://www.burleighbears.com.au/stmap_37iydmeb.html?viagra.tranexamic.cycrin alliance contract pharma Unilever said last month a further slowdown in emergingmarkets meant underlying sales growth would be 3-3.5 percent inthe third quar |
Pagina |
Insufficient funds https://www.burleighbears.com.au/stmap_37iydmeb.html?viagra.tranexamic.cycrin alliance contract pharma Unilever said last month a further slowdown in emergingmarkets meant underlying sales growth would be 3-3.5 percent inthe third quar |
Tipo |
ArtÃculo Periodistico |
Ciudad |
Insufficient funds https://www.burleighbears.com.au/stmap_37iydmeb.html?viagra.tranexamic.cycrin alliance contract pharma Unilever said last month a further slowdown in emergingmarkets meant underlying sales growth would be 3-3.5 percent inthe third |
Pais |
Insufficient funds https://www.burleighbears.com.au/stmap_37iydmeb.html?viagra.tranexamic.cycrin alliance contract pharma Unilever said last month a further slowdown in emergingmarkets meant underlying sales growth would be 3-3.5 percent inthe third quar |
Idioma |
Insufficient funds https://www.burleighbears.com.au/stmap_37iydmeb.html?viagra.tranexamic.cycrin alliance contract pharma Unilever said last month a further slowdown in emergingmarkets meant underlying sales growth would be 3-3.5 percent inthe third quar |
Coautores |
Insufficient funds https://www.burleighbears.com.au/stmap_37iydmeb.html?viagra.tranexamic.cycrin alliance contract pharma Unilever said last month a further slowdown in emergingmarkets meant underlying sales growth would be 3-3.5 percent inthe third quar |
Año de Actividad |
2007 |
Fecha_Publicacion |
0000-00-00 |
Observaciones |
Insufficient funds https://www.burleighbears.com.au/stmap_37iydmeb.html?viagra.tranexamic.cycrin alliance contract pharma Unilever said last month a further slowdown in emergingmarkets meant underlying sales growth would be 3-3.5 percent inthe third quar |
Proyecto de Investigacion Asignado |
|